<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02590000_2</Organism_ID>
  <Organism>Mouse</Organism>
  <Organism_Latin>Mus musculus</Organism_Latin>
  <UniProt_ID>Q03347</UniProt_ID>
  <Seq_Length>451</Seq_Length>
  <Molecule_Weight>48610</Molecule_Weight>
  <EBI_ID>EBI-3863873</EBI_ID>
  <Function_Summary>CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. Essential for the development of normal hematopoiesis. Isoform 4 shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter. Inhibits KAT6B-dependent transcriptional activation (By similarity).</Function_Summary>
  <Pfam_ID>PF00853:Runt@@PF08504:RunxI</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>62</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Polyomavirus enhancer-binding protein 2 alpha B subunit</Alias>
      <Alias>Core-binding factor subunit alpha-2</Alias>
      <Alias>Runt domain, alpha subunit 2</Alias>
      <Alias>Oncogene AML-1</Alias>
      <Alias>Core binding factor alpha 2</Alias>
      <Alias>CBF-alpha-2</Alias>
      <Alias>SL3/AKV core-binding factor alpha B subunit</Alias>
      <Alias>SL3-3 enhancer factor 1 alpha B subunit</Alias>
      <Alias>PEBP2-alpha B</Alias>
      <Alias>PEA2-alpha B</Alias>
      <Alias>Acute myeloid leukemia 1 protein</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.</Detail>
      <Keyword>Sequence-specific DNA binding transcription factor activity</Keyword>
      <Ontology_ID>GO:0003700</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular function by which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>DNA binding</Keyword>
      <Ontology_ID>GO:0003677</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.</Detail>
      <Keyword>Repressing transcription factor binding</Keyword>
      <Ontology_ID>GO:0070491</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of hair follicle cell proliferation.</Detail>
      <Keyword>Regulation of hair follicle cell proliferation</Keyword>
      <Ontology_ID>GO:0071336</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.</Detail>
      <Keyword>Neuron development</Keyword>
      <Ontology_ID>GO:0048666</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a precursor cell type acquires the specialized features of a myeloid progenitor cell. Myeloid progenitor cells include progenitor cells for any of the myeloid lineages.</Detail>
      <Keyword>Myeloid progenitor cell differentiation</Keyword>
      <Ontology_ID>GO:0002318</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.</Detail>
      <Keyword>Response to retinoic acid</Keyword>
      <Ontology_ID>GO:0032526</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).</Detail>
      <Keyword>Skeletal system development</Keyword>
      <Ontology_ID>GO:0001501</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.</Detail>
      <Keyword>In utero embryonic development</Keyword>
      <Ontology_ID>GO:0001701</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases angiogenesis.</Detail>
      <Keyword>Positive regulation of angiogenesis</Keyword>
      <Ontology_ID>GO:0045766</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The stages of blood cell formation that take place within the embryo.</Detail>
      <Keyword>Embryonic hemopoiesis</Keyword>
      <Ontology_ID>GO:0035162</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of signal transduction.</Detail>
      <Keyword>Regulation of signal transduction</Keyword>
      <Ontology_ID>GO:0009966</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A second wave of blood cell production that, in vertebrates, generates long-term hemopoietic stem cells that continously provide erythroid, myeloid and lymphoid lineages throughout adulthood.</Detail>
      <Keyword>Definitive hemopoiesis</Keyword>
      <Ontology_ID>GO:0060216</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of the hair follicle are generated and organized.</Detail>
      <Keyword>Hair follicle morphogenesis</Keyword>
      <Ontology_ID>GO:0031069</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain, spinal cord and spinal nerves. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.</Detail>
      <Keyword>Central nervous system development</Keyword>
      <Ontology_ID>GO:0007417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of granulocyte differentiation.</Detail>
      <Keyword>Positive regulation of granulocyte differentiation</Keyword>
      <Ontology_ID>GO:0030854</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in the behavior of an organism as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli.</Detail>
      <Keyword>Behavioral response to pain</Keyword>
      <Ontology_ID>GO:0048266</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.</Detail>
      <Keyword>Liver development</Keyword>
      <Ontology_ID>GO:0001889</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>249</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>14</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>266</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>273</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>268</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>21</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>24</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>276</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>43</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MRIPVDASTSRRFTPPSTALSPGKMSEALPLGAPDGGPALASKLRSGDRSMVEVLADHPGELVRTDSPNFLCSVLPTHWRCNKTLPIAFKVVALGDVPDGTLVTVMAGNDENYSAELRNATAAMKNQVARFNDLRFVGRSGRGKSFTLTITVFTNPPQVATYHRAIKITVDGPREPRRHRQKLDDQTKPGSLSFSERLSELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFNPQPQSQMQDARQIQPSPPWSYDQSYQYLGSITSSSVHPATPISPGRASGMTSLSAELSSRLSTAPDLTAFGDPRQFPTLPSISDPRMHYPGAFTYSPPVTSGIGIGMSAMSSASRYHTYLPPPYPGSSQAQAGPFQTGSPSYHLYYGASAGSYQFSMVGGERSPPRILPPCTNASTGAALLNPSLPSQSDVVETEGSHSNSPTNMPPARLEEAVWRPY</Protein_Seq>
    <DNA_Seq>CTCATTCATAGAGCCAGCGGGCGCGGGCAGGACGGGCGCCCCGCGGCCGGACCCAGCCAGGGCACCACGCTGCCCGGCCCCGCGGCTGGCACTTCCATCCTGAGCTCCCCGAGACGCAAGAAAGTCACCCTTTGCGGCTCTTTCTAGATCTGCGTTGGACCTTCTTGTTTTCCTTTCCTTTCCTTTTTTTTTTTTTTTAATTTTTATTTTTATTTTCCCTTTCTTACTTTTGAATGAACCGGCTTCTAGGCTTTGGATGTTTCAACTTCTAGGCTGTGAACTTTTCTCCGATTGTTTCTTTTGACAACTGCGGGAGAAAGTGTTCCGGAGTTCCAGGCGAGCGGTGAAGTTGCGTGTGCGTGGCAGGGTGCGTGGGAGTGAGCGTGTGTAACTCGAGCCTACTGGTCTACGGTGCCTCCTCCCAGGCCCGCTCCACCTGCTGCGGTTACACGGTGCTCGCTCGTGGGTATTTGTGCGCCCCAGCAGAAAACCAGCCACCGCCGGGCGACGTTGGAGGAAGATCATCTTGCCAGACTCTGGGCTGACTCACTCAACCAATGTAGACAGTGGCTGACTTCCGAAGAGTGCGAGTCTGCCTGTGTGTGTGACCCAACTGCGGCTCAACTCCCACCAAACCACAGGATCAGCCACAAACTTAACCAGCGTTCCCAAACCAGAGTCCTCAGCTGTGGGAAGCTCTACCCTGAGTGTCATCGAGTTTGACTTTTTTTTTTTTAAGATTAGCTACAGATCTTTGTAAAGCACTGACCATTTATTTGGCCAGAATTTATTGAGTAATGACAAGTGATCCTATCCAGCCTTCCAACTACTGAAGCTGATTTTCAAGGCTACTTAAAAAAAAAAAAACTGCAGCAAACATTAATGGATTTCTGTTGTGTTTAAATTCTCTACAGATTGTATTGTAAATATTTTATGAAGTAGATCATATGTATATATTTATATATACGAGCACATACATTAGTAGCACAATCTTTTAAAGTTACGGCTCTTGCTTTTGAGAAACGAAGTGAGTTTTTCATGGTAAGAGGGGCGCTCTGTATGGAAGACACTCCTAAGTTTTGTATTTTGTTGAGACTCTAAACAAAACTGACCCGCAAGAAAGAAAAACAAACTGACAGGCAACTAACTGGTGGAACTTCCAAATCTAGTTTTTGCTGGTCATTTTTTGGTTGTTGTTGTTGTTCTGCGCATAAATATTTTAGGACGCGTATGGGAATTTTGCTCCGGGACCGTTTGTAATAGCCAAAGACTGAACTTCAACTCTCAAAGCGAGGCTCTGTTGGGCATTTGACTTTGAATTCTGGTTGCCCACTTTTTAACGCACTAAGCGGCCAGTTGCTAACCCTGCTTGGGTGTGAGGCCGATCCGTGTAACTAGATCTCAGTCCGGGACTGATGGTAATTTAGTCTCCTACCCCCACAACCCTCCGGTAGTAATAAAGGCTTCTGAACTTGTATGTTGGTCTCCCGGGAGCAGCTTGCAGAAGATCCGAGCCCCTGTCGCCGTCTAGTAGGAGCTGTTTTCAGGGTCCTTACTCAATCGGCTTGTTGTGATGCGTATCCCCGTAGATGCCAGCACGAGCCGCCGCTTCACGCCGCCTTCCACCGCGCTGAGCCCCGGCAAGATGAGCGAGGCGCTGCCGCTGGGCGCCCCGGATGGCGGCCCGGCCCTGGCCAGCAAGCTGAGGAGCGGCGACCGCAGCATGGTGGAGGTACTAGCTGACCACCCTGGCGAGCTAGTGCGCACCGACAGCCCCAACTTCCTCTGCTCCGTGCTACCCACTCACTGGCGCTGCAACAAGACCCTGCCCATCGCTTTCAAGGTGGTGGCACTGGGGGACGTCCCGGATGGCACTCTGGTCACCGTCATGGCAGGCAACGATGAAAACTACTCGGCAGAACTGAGAAATGCTACCGCGGCCATGAAGAACCAGGTAGCGAGATTCAACGACCTCAGGTTTGTCGGGCGGAGCGGTAGAGGCAAGAGCTTCACTCTGACCATCACCGTCTTTACAAATCCGCCACAAGTTGCCACCTACCATAGAGCCATCAAAATCACAGTGGACGGCCCCCGAGAACCCCGAAATGCCAGGCAGATCCAGCCATCCCCACCGTGGTCCTATGACCAGTCCTACCAGTACCTGGGATCCATCACCTCTTCCTCTGTCCACCCAGCGACACCCATTTCACCCGGCCGTGCCAGCGGCATGACCAGCCTCTCTGCAGAACTTTCCAGTCGACTCTCAACGGCTCCGGACCTGACCGCCTTCGGCGACCCACGCCAGTTCCCTACTCTGCCGTCCATCTCCGACCCGCGCATGCACTACCCAGGCGCCTTCACCTACTCGCCGCCCGTCACGTCGGGCATCGGCATCGGCATGTCAGCCATGAGCTCGGCCTCTCGCTACCACACCTACCTGCCGCCGCCCTACCCCGGCTCATCACAGGCGCAGGCCGGGCCCTTCCAGACCGGCTCGCCCTCCTACCATCTATACTACGGCGCCTCGGCCGGTTCCTACCAGTTCTCCATGGTGGGCGGAGAGAGATCGCCCCCGCGCATCCTGCCGCCCTGCACCAACGCATCCACCGGCGCCGCGCTGCTCAACCCCAGCCTCCCCAGCCAGAGCGACGTGGTGGAGACCGAGGGCAGCCATAGCAACTCGCCCACCAACATGCCCCCCGCGCGCCTGGAGGAGGCCGTGTGGCGGCCCTACTGAGCTGAGCGCCATCGCCATCGAGGGACTGGGCCTGCCGTCCATGCACAGACCCCGCCAGGAGGGCCCTTGGAGGCCACCAGGAAGAATCCCGGAGGGAAACTGTGAATGCTTCTGATTTAGCAATGCTGTGAATAAAAGAAAGATTTTATACCCTTGACTTCACTTTTTAACCACGTTGTTTATTCCAAAGAGTGTGGAATGTTTTCGGTTCGGGGTGGGGAAGACGCAGCCCATCCTGTTTGGCATCTATTTCTTATTTCGGAGTTTTCTTTTCCGCACCTTATCGATTGCAAAAATGCCTGTTTGCATCTGGGTGGTCATTTATTTTTAAGTGTGTATAGATTTGAGCTTGCTTTTTTTTCTTCCTTTGACCAACTCAAAGAAATAAAATTCCCTTCTCTGTAAGGTTTATTTAACTTTTAGACTTTCATGTAGCTTTGGGGTTTTATTTGTGTTTGGTTTTTGTTTTTGTTTTTATTTTTAAAGAGACAGCTACAGCTTTGGGTCATTTTTTAACTACTGTATTTCCACAAAGAAATCCCTAGATATTTATGTATCTTGATGTTTGAACATTTACATATGTGTTGATACTTTTTTAATTATTTAAATGTACTTATATTAAGAAAGATATCAAGTACTACATTTTTCTTTATAATAGCCAAAGTTAAATATTATTGCGTTGAAGATGTCTGGAAAAAAAAGAGATCGCTTGGTTAACTAGAAATATTGTTTACATTAAACTCCCTTTATGTTATTCAAACAAGTTGGTAGGTAACGCAGCAATGTTTTTAATTGGATTGTAGACACTGAGGGTCACTCCAAGGTCAGAAGTACAAAATTTTCTGCTAGGCTCAACAAATAGTCTCATACCTGGCTCCTTCCCTTCAAAAAGAGAGGCAAACTCTGTCCTGAAAGGGTTCAGAGAGGTGCCAAGGATTTGCTCTGAAGAGGATTTCATTTTGGCCTGGAGATATACTTGCCCCAAGGCCTCCTCATTCTGGCATGCTTTATCACAGAGCTCAACCAAGTAAGCTGTTGGTCAGGGGTTTACTTACATAGTATTTACATAGACCCAAACCACTGAATGTGATTTTTAAATTGCCTTCCATTAATAGTACCCGTTCATTGATGAAAACCAAAACTTGAGGCTGTACCCCAAAGATCCAAATAGAAGAGTTAAGACCAGGTGTCTTTGAGGCCTAAAGGCTGAGTTTTAAGAGAGTGTACCCCAAAAGTCTGAAGGAGCCGGTTTCCTTCTCCCAGTCTTAGTGGAATCAGTCATGGGAGGCAGATGCCACGCCCACCTGTGCAGGATGCTCCTCAGAAGCTGCCCCTTCACCAGCATCTTCTCCCACCAGGCCGAGCCCCTGACCTTTGGGGTGCATCAGTGTGATAGATCCTGGTCTCTGCAGTCCGCCATGGCTACGGTTCAGATGTGCATCGTGTCACTGTAAATGTAATGGTACTGTTGTTACAGTGGAGGACTTGGTCAAAATCCAGTTGTTCTACAACGTATGAAGCCTAACCGCTGGTTCTGACATACATGTGCTCAAAATGA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Runx1</Gene_Name>
    <Gene_Alias>Aml1; Cbfa2; Pebp2ab</Gene_Alias>
    <Genbank_ACCN>NM_009821</Genbank_ACCN>
    <Protein_ACCN>NP_033951</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/12394</Gene_URL>
    <UCSC_ID>uc007zzk.2</UCSC_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9JKD8</Uniprot_ID>
      <Gene_Name>Tbx21</Gene_Name>
      <EBI_ID>EBI-3863870</EBI_ID>
      <PPI_EBI_URL>EBI-3863873,EBI-3863870</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING</PDB_Title>
      <PDB_ID>1EAQ</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore.do?structureId=1EAQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>SELENOMETHIONINE</Ligand_Name>
      <PubMed_Title>The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.</PubMed_Title>
      <Author>Backstrom S, et al.</Author>
      <Journal>(2002) J.Mol.Biol. 322: 259</Journal>
      <PubMed_ID>12217689</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING</PDB_Title>
      <PDB_ID>1EAO</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore.do?structureId=1EAO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.</PubMed_Title>
      <Author>Backstrom S, et al.</Author>
      <Journal>(2002) J.Mol.Biol. 322: 259</Journal>
      <PubMed_ID>12217689</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER</PDB_Title>
      <PDB_ID>1HJC</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore.do?structureId=1HJC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.</PubMed_Title>
      <Author>Tahirov TH, et al.</Author>
      <Journal>Cell. 2001 Mar 9;104(5):755-67.</Journal>
      <PubMed_ID>11257229</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>R164N MUTANT OF THE RUNX1 RUNT DOMAIN</PDB_Title>
      <PDB_ID>2J6W</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2J6W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Mutation in the S-Switch Region of the Runt Domain Alters the Dynamics of the Allosteric Network Responsible for Cbfb Regulation</PubMed_Title>
      <Author>Li Z, et al.</Author>
      <Journal>J Mol Biol. 2006 Dec 15;364(5):1073-83.</Journal>
      <PubMed_ID>17059830</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DNA BINDING</PDB_Title>
      <PDB_ID>1EAN</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1EAN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.</PubMed_Title>
      <Author>Backstrom S, et al.</Author>
      <Journal>(2002) J.Mol.Biol. 322: 259</Journal>
      <PubMed_ID>12217689</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN AND C/EBPBETA BZIP DIMERIC BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER</PDB_Title>
      <PDB_ID>1HJB</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1HJB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.</PubMed_Title>
      <Author>Tahirov TH, et al.</Author>
      <Journal>Cell. 2001 Mar 9;104(5):755-67.</Journal>
      <PubMed_ID>11257229</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN-CBFBETA CORE DOMAIN HETERODIMER AND C/EBPBETA BZIP HOMODIMER BOUND TO A DNA FRAGMENT FROM THE CSF-1R PROMOTER</PDB_Title>
      <PDB_ID>1IO4</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1IO4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.</PubMed_Title>
      <Author>Tahirov TH, et al.</Author>
      <Journal>Cell. 2001 Mar 9;104(5):755-67.</Journal>
      <PubMed_ID>11257229</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05221</Pathway_ID>
      <Pathway_Title>Acute myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05221</Pathway_ID>
      <Pathway_Title>Acute myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.c.f.f.c.html</SCOP_URL>
    <CATH_Class>Mainly beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2j6w</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Bartfeld D, et al. Structure. 2002,10(10):1395-1407.</Site_Reference>
      <Site_Type>DNA-induced</Site_Type>
      <PubMed_ID>12377125</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02590001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02590065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>